Global Non absorbable Surgical Suture Market Size By Type (Nylon, Polypropylene), By Application (Clinic, Hospital), By Region, And Segment Forecasts, 2023 to 2032

The Global Non-Absorbable Surgical Suture Market was valued at USD 1.62 billion in 2023 and is projected to reach USD 2.45 billion by 2031, growing at a CAGR of 5.3% during the forecast period of 2023–2031. Non-absorbable surgical sutures, designed for long-term wound closure and strength retention, are widely used in procedures where extended healing support is necessary, such as cardiovascular, orthopedic, and general surgeries. Market growth is propelled by rising surgical volumes globally, increased geriatric population, and continuous advancements in suture technology and biocompatibility.

Drivers:

1. Increasing Surgical Procedures Worldwide:

A global uptick in elective and emergency surgeries, especially in developing economies, is a primary driver. Procedures requiring long-term wound support, such as cardiovascular and orthopedic surgeries, prominently utilize non-absorbable sutures.

2. Technological Advancements in Suture Material:

Continuous R&D has led to enhanced suture materials with improved strength, elasticity, and reduced tissue reactivity. Innovations like antimicrobial-coated sutures are gaining traction in reducing post-surgical infections.

3. Growing Geriatric Population:

The aging population is more prone to chronic diseases requiring surgical intervention. This demographic trend is significantly boosting the demand for durable wound closure products like non-absorbable sutures.

Restraints:

1. Risk of Infection and Inflammation:

Despite their utility, non-absorbable sutures carry a higher risk of infection and inflammatory responses compared to absorbable alternatives, particularly in immunocompromised patients.

2. Rising Adoption of Minimally Invasive Procedures:

The increasing shift towards minimally invasive and suture-less surgical procedures—such as laparoscopic and robotic surgeries—could restrain market growth in the long term.

Opportunity:

1. Market Penetration in Emerging Economies:

Healthcare infrastructure improvements in Asia-Pacific and Latin America present robust growth opportunities. Government investments and rising health awareness are encouraging adoption of advanced surgical products.

2. Customization and Smart Sutures:

Opportunities lie in developing smart sutures that monitor healing, as well as customizable suture kits designed for specific tissue types, which cater to niche surgical needs.

Market by System Type Insights:

Based on system type, Monofilament Sutures dominated the market in 2023 due to their low tissue drag and reduced infection risk. However, Braided Sutures are anticipated to witness steady demand due to superior knot security, especially in cardiovascular and gastrointestinal surgeries. The choice largely depends on surgical site and practitioner preference.

Market by End-use Insights:

In 2023, Hospitals accounted for the largest market share owing to the high volume of surgeries performed in these settings. Ambulatory Surgical Centers (ASCs) are emerging rapidly due to cost-effective and short-stay surgical procedures, offering a high-growth segment for non-absorbable sutures.

Market by Regional Insights:

North America led the market in 2023, backed by a strong surgical infrastructure, high healthcare expenditure, and favorable reimbursement policies. Asia-Pacific is projected to grow at the fastest pace due to an increasing patient pool, expanding medical tourism industry, and improving access to surgical care in countries like India, China, and Indonesia.

Competitive Scenario:

Key players in the market include Johnson & Johnson (Ethicon), Medtronic plc, B. Braun Melsungen AG, Smith & Nephew, DemeTech Corporation, Conmed Corporation, Sutures India Pvt. Ltd., and Teleflex Incorporated. These companies are engaged in R&D, product innovation, and strategic partnerships to enhance their global footprint. For instance:

In 2023, Ethicon launched a new series of antimicrobial non-absorbable sutures aimed at reducing surgical site infections (SSI).

In 2024, Medtronic announced a strategic collaboration with surgical centers in Latin America to provide suture solutions tailored to regional needs.

Scope of Work – Global Non-Absorbable Surgical Suture Market

Report Metric Details

Market Size (2023) USD 1.62 billion

Projected Market Size (2031) USD 2.45 billion

CAGR (2023–2031) 5.3%

Market Segments By System Type (Monofilament, Braided), By End-use (Hospitals, ASCs, Clinics), By Region

Growth Drivers Increasing surgical volumes, technological innovation, aging population

Opportunities Smart sutures, expansion in emerging economies

Key Market Developments:

2023: Johnson & Johnson launched the PROLENE Antibacterial suture with extended-release technology.

2024: DemeTech Corporation expanded its production facility to meet rising demand from Southeast Asia.

2025: B. Braun introduced eco-friendly packaging for its suture product line, enhancing its sustainability efforts.

FAQs:

1) What is the current market size of the Global Non-Absorbable Surgical Suture Market?

The market size in 2023 is valued at USD 1.62 billion.

2) What is the major growth driver of the Global Non-Absorbable Surgical Suture Market?

The primary growth driver is the increasing global volume of surgical procedures and advancements in suture material.

3) Which is the largest region during the forecast period in the Global Non-Absorbable Surgical Suture Market?

North America remains the largest region due to established surgical infrastructure and high healthcare spending.

4) Which segment accounted for the largest market share in Global Non-Absorbable Surgical Suture Market?

The Hospital end-use segment accounted for the largest share in 2023.

5) Who are the key market players in the Global Non-Absorbable Surgical Suture Market?

Key players include Johnson & Johnson (Ethicon), Medtronic plc, B. Braun Melsungen AG, Smith & Nephew, and DemeTech Corporation.